Soluble Mediators, Not Cilia, Determine Airway Surface Liquid Volume in Normal and Cystic Fibrosis Superficial Airway Epithelia

por Tarran, Robert, Trout, Laura, Donaldson, Scott H., Boucher, Richard C.
Publicado 2006

Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease

por Lamas, Adelaida, Marshburn, Jamie, Stober, Vandy P., Donaldson, Scott H., Garantziotis, Stavros
Publicado 2016

Dynamic Perfluorinated Gas MRI Shows Improved Lung Ventilation in People with Cystic Fibrosis after Elexacaftor/Tezacaftor/Ivacaftor: An Observational Study

por Goralski, Jennifer L., Chung, Sang Hun, Ceppe, Agathe S., Powell, Margret Z., Sakthivel, Muthu, Handly, Brian D., Lee, Yueh Z., Donaldson, Scott H.
Publicado 2022

Comparison of single breath hyperpolarized (129)Xe MRI with dynamic (19)F MRI in cystic fibrosis lung disease

por McCallister, Andrew, Chung, Sang Hun, Antonacci, Michael, Z. Powell, Margret, Ceppe, Agathe S., Donaldson, Scott H., Lee, Yueh Z., Branca, Rosa Tamara, Goralski, Jennifer L.
Publicado 2020

Novel Outcome Measures for Clinical Trials in Cystic Fibrosis

por Tiddens, Harm AWM, Puderbach, Michael, Venegas, Jose G, Ratjen, Felix, Donaldson, Scott H, Davis, Stephanie D, Rowe, Steven M, Sagel, Scott D, Higgins, Mark, Waltz, David A
Publicado 2015

Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis

por Bennett, William D., Henderson, Ashley G., Ceppe, Agathe, Zeman, Kirby L., Wu, Jihong, Gladman, Christine, Fuller, Fred, Gazda, Stephen, Button, Brian, Boucher, Richard C., Donaldson, Scott H.
Publicado 2020

A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease

por Hill, David B., Vasquez, Paula A., Mellnik, John, McKinley, Scott A., Vose, Aaron, Mu, Frank, Henderson, Ashley G., Donaldson, Scott H., Alexis, Neil E., Boucher, Richard C., Forest, M. Gregory
Publicado 2014

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study

por van Koningsbruggen-Rietschel, Silke, Davies, Jane C., Pressler, Tacjana, Fischer, Rainald, MacGregor, Gordon, Donaldson, Scott H., Smerud, Knut, Meland, Nils, Mortensen, Jann, Fosbøl, Marie Ø., Downey, Damian G., Myrset, Astrid H., Flaten, Hugo, Rye, Philip D.
Publicado 2020

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design

por Mayer-Hamblett, Nicole, Nichols, David P., Odem-Davis, Katherine, Riekert, Kristin A., Sawicki, Greg S., Donaldson, Scott H., Ratjen, Felix, Konstan, Michael W., Simon, Noah, Rosenbluth, Daniel B., Retsch-Bogart, George, Clancy, John P., VanDalfsen, Jill M., Buckingham, Rachael, Gifford, Alex H.
Publicado 2021

Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function

por Clancy, John P., Szczesniak, Rhonda D., Ashlock, Melissa A., Ernst, Sarah E., Fan, Lijuan, Hornick, Douglas B., Karp, Philip H., Khan, Umer, Lymp, James, Ostmann, Alicia J., Rezayat, Amir, Starner, Timothy D., Sugandha, Shajan P., Sun, Hongtao, Quinney, Nancy, Donaldson, Scott H., Rowe, Steven M., Gabriel, Sherif E.
Publicado 2013

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

por Nichols, David P., Paynter, Alex C., Heltshe, Sonya L., Donaldson, Scott H., Frederick, Carla A., Freedman, Steven D., Gelfond, Daniel, Hoffman, Lucas R., Kelly, Andrea, Narkewicz, Michael R., Pittman, Jessica E., Ratjen, Felix, Rosenfeld, Margaret, Sagel, Scott D., Schwarzenberg, Sarah Jane, Singh, Pradeep K., Solomon, George M., Stalvey, Michael S., Clancy, John P., Kirby, Shannon, Van Dalfsen, Jill M., Kloster, Margaret H., Rowe, Steven M.
Publicado 2021